Masimo ROE 2010-2024 | MASI
Current and historical return on equity (ROE) values for Masimo (MASI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Masimo ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $0.08B | $1.46B | 5.68% |
| 2024-06-30 | $0.08B | $1.37B | 5.95% |
| 2024-03-31 | $0.08B | $1.37B | 6.02% |
| 2023-12-31 | $0.08B | $1.37B | 6.21% |
| 2023-09-30 | $0.09B | $1.28B | 6.78% |
| 2023-06-30 | $0.12B | $1.31B | 8.87% |
| 2023-03-31 | $0.12B | $1.33B | 9.21% |
| 2022-12-31 | $0.14B | $1.34B | 10.71% |
| 2022-09-30 | $0.17B | $1.25B | 12.24% |
| 2022-06-30 | $0.19B | $1.20B | 13.17% |
| 2022-03-31 | $0.22B | $1.58B | 14.89% |
| 2021-12-31 | $0.23B | $1.55B | 15.97% |
| 2021-09-30 | $0.23B | $1.47B | 16.59% |
| 2021-06-30 | $0.22B | $1.39B | 16.10% |
| 2021-03-31 | $0.23B | $1.33B | 16.67% |
| 2020-12-31 | $0.24B | $1.41B | 17.71% |
| 2020-09-30 | $0.22B | $1.42B | 17.14% |
| 2020-06-30 | $0.22B | $1.35B | 18.22% |
| 2020-03-31 | $0.21B | $1.25B | 18.47% |
| 2019-12-31 | $0.20B | $1.17B | 18.14% |
| 2019-09-30 | $0.19B | $1.11B | 18.44% |
| 2019-06-30 | $0.20B | $1.04B | 20.17% |
| 2019-03-31 | $0.20B | $1.01B | 21.23% |
| 2018-12-31 | $0.19B | $0.97B | 22.34% |
| 2018-09-30 | $0.14B | $0.91B | 17.22% |
| 2018-06-30 | $0.12B | $0.83B | 15.56% |
| 2018-03-31 | $0.12B | $0.77B | 16.32% |
| 2017-12-31 | $0.13B | $0.72B | 17.96% |
| 2017-09-30 | $0.36B | $0.72B | 54.81% |
| 2017-06-30 | $0.35B | $0.71B | 62.79% |
| 2017-03-31 | $0.34B | $0.63B | 73.77% |
| 2016-12-31 | $0.31B | $0.56B | 85.71% |
| 2016-09-30 | $0.11B | $0.33B | 37.54% |
| 2016-06-30 | $0.10B | $0.30B | 36.50% |
| 2016-03-31 | $0.09B | $0.27B | 32.85% |
| 2015-12-31 | $0.08B | $0.28B | 28.79% |
| 2015-09-30 | $0.08B | $0.27B | 27.00% |
| 2015-06-30 | $0.08B | $0.28B | 25.31% |
| 2015-03-31 | $0.07B | $0.33B | 22.98% |
| 2014-12-31 | $0.07B | $0.31B | 23.10% |
| 2014-09-30 | $0.06B | $0.28B | 19.03% |
| 2014-06-30 | $0.06B | $0.32B | 18.90% |
| 2014-03-31 | $0.07B | $0.35B | 20.22% |
| 2013-12-31 | $0.06B | $0.33B | 19.11% |
| 2013-09-30 | $0.06B | $0.31B | 21.99% |
| 2013-06-30 | $0.06B | $0.29B | 21.31% |
| 2013-03-31 | $0.06B | $0.28B | 21.61% |
| 2012-12-31 | $0.06B | $0.28B | 21.67% |
| 2012-09-30 | $0.06B | $0.31B | 21.25% |
| 2012-06-30 | $0.06B | $0.30B | 21.91% |
| 2012-03-31 | $0.06B | $0.28B | 21.87% |
| 2011-12-31 | $0.06B | $0.28B | 23.04% |
| 2011-09-30 | $0.07B | $0.30B | 24.88% |
| 2011-06-30 | $0.07B | $0.28B | 26.51% |
| 2011-03-31 | $0.06B | $0.26B | 26.69% |
| 2010-12-31 | $0.07B | $0.23B | 31.98% |
| 2010-09-30 | $0.07B | $0.25B | 29.19% |
| 2010-06-30 | $0.07B | $0.23B | 27.28% |
| 2010-03-31 | $0.07B | $0.21B | 26.17% |
| 2009-12-31 | $0.05B | $0.29B | 20.17% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.193B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.293B | 24.68 |
| Intuitive Surgical (ISRG) | United States | $195.881B | 102.41 |
| Edwards Lifesciences (EW) | United States | $43.763B | 27.79 |
| Alcon (ALC) | Switzerland | $43.327B | 28.99 |
| IQVIA Holdings (IQV) | United States | $36.875B | 20.32 |
| IDEXX Laboratories (IDXX) | United States | $35.573B | 41.89 |
| DexCom (DXCM) | United States | $31.642B | 47.65 |
| Waters (WAT) | United States | $23.237B | 34.36 |
| STERIS (STE) | Ireland | $21.444B | 24.69 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.134B | 0.00 |
| Hologic (HOLX) | United States | $17.445B | 18.84 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.790B | 14.16 |
| Sysmex ADR (SSMXY) | Japan | $13.236B | 41.51 |
| Globus Medical (GMED) | United States | $11.494B | 29.11 |
| Penumbra (PEN) | United States | $9.559B | 93.64 |
| Teleflex (TFX) | United States | $8.700B | 13.88 |
| Glaukos (GKOS) | United States | $7.624B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.190B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.713B | 26.71 |
| Veracyte (VCYT) | United States | $3.417B | 102.54 |
| Inari Medical (NARI) | United States | $3.056B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.780B | 16.05 |
| TransMedics (TMDX) | United States | $2.423B | 76.82 |
| Nihon Kohden (NHNKY) | Japan | $2.410B | 18.31 |
| Elekta AB (EKTAY) | Sweden | $2.150B | 19.33 |
| Tandem Diabetes Care (TNDM) | United States | $2.120B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| RxSight (RXST) | United States | $1.740B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.425B | 0.00 |
| Artivion (AORT) | United States | $1.243B | 82.36 |
| Pulse Biosciences (PLSE) | United States | $1.217B | 0.00 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.878B | 14.92 |
| Paragon 28 (FNA) | United States | $0.830B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.716B | 0.00 |
| IRadimed (IRMD) | United States | $0.693B | 37.48 |
| Mesa Laboratories (MLAB) | United States | $0.686B | 16.17 |
| AxoGen (AXGN) | United States | $0.653B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.591B | 0.00 |
| SiBone (SIBN) | United States | $0.578B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.570B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.525B | 30.93 |
| Treace Medical Concepts (TMCI) | United States | $0.502B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.456B | 24.70 |
| Delcath Systems (DCTH) | United States | $0.365B | 0.00 |
| CVRx (CVRX) | United States | $0.359B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.351B | 0.00 |
| NeuroPace (NPCE) | United States | $0.334B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.243B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.155B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.147B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.142B | 15.16 |
| Spectral Diagnostics (EDTXF) | Canada | $0.110B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.085B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.081B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.052B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.046B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.040B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |